These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19997805)

  • 1. Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: report of a case.
    Kim MJ; Yun SH; Chun HK; Lee WY; Cho YB
    Surg Today; 2009; 39(12):1076-9. PubMed ID: 19997805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant Lymphoproliferative Disorder in Recipient's Reconstructed Middle Hepatic Vein After Pediatric Living Donor Liver Transplant: A Case Report.
    Li H; Zhu Z; Wei L; Zeng Z; Qu W
    Transplant Proc; 2021 May; 53(4):1308-1312. PubMed ID: 33358421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kidney transplant large bowel lymphoproliferative disorder.
    Singh N; Samavedi S; Rajab A
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):621-4. PubMed ID: 24821162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature.
    Kataoka K; Seo S; Sugawara Y; Ota S; Imai Y; Takahashi T; Fukayama M; Kokudo N; Kurokawa M
    Leuk Lymphoma; 2010 Aug; 51(8):1494-501. PubMed ID: 20578817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.
    Haruki K; Shiba H; Shimada J; Okui N; Iida T; Yanaga K
    Clin J Gastroenterol; 2017 Feb; 10(1):47-51. PubMed ID: 27796825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
    Koffman BH; Kennedy AS; Heyman M; Colonna J; Howell C
    Int J Cancer; 2000 Apr; 90(2):104-9. PubMed ID: 10814960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant lymphoproliferative disorder resembling Wilms tumor. Diagnostic dilemma: renal biopsy or nephrectomy?
    Cheng E; Fustino N; Klesse L; Chinnakotla S; Sanghavi R
    Pediatr Transplant; 2011 Dec; 15(8):E187-91. PubMed ID: 20670357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).
    Krasuska-Sławińska E; Minko-Chojnowska I; Pawłowska J; Dembowska-Bagińska B; Pronicki M; Olczak-Kowalczyk D
    Ann Transplant; 2015 Aug; 20():478-82. PubMed ID: 26285106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive Epstein-Barr virus-negative B-cell post-transplant lymphoproliferative disorder in a hepatitis C-negative liver transplant recipient who received a hepatitis C-positive graft: Implications for D+/R- hepatitis C virus seroconversion.
    Kutzler HL; Collins K; Maneckshana B; Rochon C; Einstein M; Mnayer L; Rezuke WN; Sheiner P; Serrano OK
    Transpl Infect Dis; 2019 Oct; 21(5):e13144. PubMed ID: 31291501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
    Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
    Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
    Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
    Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
    Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
    Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
    Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.